CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Saved in:
| Title: | CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. |
|---|---|
| Authors: | Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Geyer SM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Nixon AB; Duke Cancer Institute, Duke University Health System, Durham, North Carolina., Innocenti F; University of North Carolina, Chapel Hill, North Carolina., Shi Q; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Kumthekar P; Alliance for Clinical Trials in Oncology Protocol Office, Chicago, Illinois., Jacobson S; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., El Dika I; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Yaqubie A; Memorial Sloan Kettering Cancer Center, New York, New York., Lopez J; Memorial Sloan Kettering Cancer Center, New York, New York., Huang B; Memorial Sloan Kettering Cancer Center, New York, New York., Tang YW; Memorial Sloan Kettering Cancer Center, New York, New York., Wen Y; University of Chicago, Chicago, Illinois., Schwartz LH; Columbia University Medical Center, New York, New York.; New York-Presbyterian Hospital, New York, New York., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, California., Knox JJ; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Rajdev L; Lenox Hill Hospital, New York, New York., Bertagnolli MM; Brigham and Women's Hospital, Boston, Massachusetts., Meyerhardt JA; Dana-Farber/Partners Cancer Care, Boston, Massachusetts., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York., Venook AP; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. |
| Source: | Cancer research communications [Cancer Res Commun] 2024 Mar 07; Vol. 4 (3), pp. 682-690. |
| Publication Type: | Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38363156 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Geyer+SM%22">Geyer SM</searchLink>; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Nixon+AB%22">Nixon AB</searchLink>; Duke Cancer Institute, Duke University Health System, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Innocenti+F%22">Innocenti F</searchLink>; University of North Carolina, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Shi+Q%22">Shi Q</searchLink>; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Kumthekar+P%22">Kumthekar P</searchLink>; Alliance for Clinical Trials in Oncology Protocol Office, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Jacobson+S%22">Jacobson S</searchLink>; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22El+Dika+I%22">El Dika I</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Yaqubie+A%22">Yaqubie A</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Lopez+J%22">Lopez J</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Huang+B%22">Huang B</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Tang+YW%22">Tang YW</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Wen+Y%22">Wen Y</searchLink>; University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Schwartz+LH%22">Schwartz LH</searchLink>; Columbia University Medical Center, New York, New York.; New York-Presbyterian Hospital, New York, New York.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Knox+JJ%22">Knox JJ</searchLink>; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rajdev+L%22">Rajdev L</searchLink>; Lenox Hill Hospital, New York, New York.<br /><searchLink fieldCode="AU" term="%22Bertagnolli+MM%22">Bertagnolli MM</searchLink>; Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Meyerhardt+JA%22">Meyerhardt JA</searchLink>; Dana-Farber/Partners Cancer Care, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22O'Reilly+EM%22">O'Reilly EM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Medical College of Cornell University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Venook+AP%22">Venook AP</searchLink>; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2024 Mar 07; Vol. 4 (3), pp. 682-690. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38363156 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2767-9764.CRC-22-0516 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 682 Titles: – TitleFull: CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abou-Alfa GK – PersonEntity: Name: NameFull: Geyer SM – PersonEntity: Name: NameFull: Nixon AB – PersonEntity: Name: NameFull: Innocenti F – PersonEntity: Name: NameFull: Shi Q – PersonEntity: Name: NameFull: Kumthekar P – PersonEntity: Name: NameFull: Jacobson S – PersonEntity: Name: NameFull: El Dika I – PersonEntity: Name: NameFull: Yaqubie A – PersonEntity: Name: NameFull: Lopez J – PersonEntity: Name: NameFull: Huang B – PersonEntity: Name: NameFull: Tang YW – PersonEntity: Name: NameFull: Wen Y – PersonEntity: Name: NameFull: Schwartz LH – PersonEntity: Name: NameFull: El-Khoueiry AB – PersonEntity: Name: NameFull: Knox JJ – PersonEntity: Name: NameFull: Rajdev L – PersonEntity: Name: NameFull: Bertagnolli MM – PersonEntity: Name: NameFull: Meyerhardt JA – PersonEntity: Name: NameFull: O'Reilly EM – PersonEntity: Name: NameFull: Venook AP IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 03 Text: 2024 Mar 07 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2767-9764 Numbering: – Type: volume Value: 4 – Type: issue Value: 3 Titles: – TitleFull: Cancer research communications Type: main |
| ResultId | 1 |